BDBM107107 US8592425, 92
SMILES: N[C@H]1CCCC(F)(F)C1NC(=O)c1nc(c(Cl)s1)-c1cnc2ccccn12
InChI Key: InChIKey=NZQSJPMVPFYPKC-LLTODGECSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Serine/threonine-protein kinase c-TAK1 (Homo sapiens (Human)) | BDBM107107 (US8592425, 92) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 720 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description MARK3 activity was assayed in vitro using a Cdc25C biotinylated peptide substrate (Cell Signalling Technologies). The phosphopeptide product was quan... | US Patent US8592425 (2013) BindingDB Entry DOI: 10.7270/Q28P5Z48 | |||||||||||
More data for this Ligand-Target Pair |